Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients with prior failure to DAA treatment

被引：0
|
作者：
Graf, Christiana [1 ]
Degasperi, Elisabetta [2 ]
D'Ambrosio, Roberta [2 ]
Llaneras, Jordi [3 ]
Vermehren, Johannes [1 ]
Dultz, Georg [1 ]
Wetzstein, Nils [4 ]
Herrmann, Eva [5 ]
Zeuzem, Stefan [1 ]
Buti, Maria
Lampertico, Pietro
Dietz, Julia [1 ]
Sarrazin, Christoph [1 ,6 ]
机构：
[1] Univ Hosp Frankfurt, Dept Internal Med, Frankfurt, Germany
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[3] UAB Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Med, Barcelona, Spain
[4] Univ Hosp Frankfurt, Dept Internal Med Infect Dis, Frankfurt, Germany
[5] Goethe Univ Frankfurt, Inst Biostatist & Math Modeling, Frankfurt, Germany
[6] St Josefs Hosp, Med Klin II, Wiesbaden, Germany
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS-129-YI
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 50 条
  • [41] Sofosbuvir-velpatasvir and sofosbuvir-velpatasvir- voxilaprevir: novel treatment options for naive and previously treated hepatitis C infection
    Shin, Hyun Phil
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (04): : 454 - 455
  • [42] Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis
    Jing Xie
    Bin Xu
    Linlin Wei
    Chunyang Huang
    Wei Liu
    Infectious Diseases and Therapy, 2022, 11 : 1661 - 1682
  • [43] Virological characterization of patients with chronic hepatitis C and failure to a glecaprevir/pibrentasvir or voxilaprevir/velpatasvir/sofosbuvir treatment in the international shared collaboration
    De Salazar, Adolfo
    Dietz, Julia
    Di Maio, Velia Chiara
    Fourati, Slim
    Mullhaupt, Beat
    Paolucci, Stefania
    Cabezas, Joaquin
    Stauber, Rudolf E.
    Coppola, Nicola
    Arenas, Juan
    Graf, Christiana
    Jimenez-Perez, Miguel
    Degasperi, Elisabetta
    Manuel Pascasio, Juan
    Callegaro, Maria Paola
    Vermehren, Johannes
    Rosales Zabal, Jose Miguel
    Battista Gaeta, Giovanni
    Garcia-Deltoro, Miguel
    Zoller, Heinz
    Puoti, Massimo
    Berg, Christoph
    Douglas, Mark
    Pawlotsky, Jean-Michel
    Howe, Anita
    Garcia Garcia, Federico
    Ceccherini Silberstein, Francesca
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2020, 73 : S107 - S108
  • [44] Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Falade-Nwulia, Oluwaseun
    Lim, Joseph K.
    JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 1215 - 1217
  • [45] Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
    Pin-Nan Cheng
    Lein-Ray Mo
    Chun-Ting Chen
    Chi-Yi Chen
    Chung-Feng Huang
    Hsing-Tao Kuo
    Ching-Chu Lo
    Kuo-Chih Tseng
    Yi-Hsiang Huang
    Chi-Ming Tai
    Cheng-Yuan Peng
    Ming-Jong Bair
    Chien-Hung Chen
    Ming-Lun Yeh
    Chih-Lang Lin
    Chun-Yen Lin
    Pei-Lun Lee
    Lee-Won Chong
    Chao-Hung Hung
    Te Sheng Chang
    Jee-Fu Huang
    Chi-Chieh Yang
    Jui-Ting Hu
    Chih-Wen Lin
    Chia-Chi Wang
    Wei-Wen Su
    Tsai-Yuan Hsieh
    Chih-Lin Lin
    Wei-Lun Tsai
    Tzong-Hsi Lee
    Guei-Ying Chen
    Szu-Jen Wang
    Chun-Chao Chang
    Sheng-Shun Yang
    Wen-Chih Wu
    Chia-Sheng Huang
    Kwok-Hsiung Chou
    Chien-Neng Kao
    Pei-Chien Tsai
    Chen-Hua Liu
    Mei-Hsuan Lee
    Chien-Yu Cheng
    Ming-Chang Tsai
    Chun-Jen Liu
    Chia-Yen Dai
    Han-Chieh Lin
    Jia-Horng Kao
    Wan-Long Chuang
    Ming-Lung Yu
    Infectious Diseases and Therapy, 2022, 11 : 485 - 500
  • [46] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
    Yuki Tahata
    Hayato Hikita
    Satoshi Mochida
    Norifumi Kawada
    Nobuyuki Enomoto
    Akio Ido
    Hitoshi Yoshiji
    Daiki Miki
    Yoichi Hiasa
    Yasuhiro Takikawa
    Ryotaro Sakamori
    Masayuki Kurosaki
    Hiroshi Yatsuhashi
    Ryosuke Tateishi
    Yoshiyuki Ueno
    Yoshito Itoh
    Taro Yamashita
    Tatsuya Kanto
    Goki Suda
    Yasunari Nakamoto
    Naoya Kato
    Yasuhiro Asahina
    Kentaro Matsuura
    Shuji Terai
    Kazuhiko Nakao
    Masahito Shimizu
    Taro Takami
    Norio Akuta
    Ryoko Yamada
    Takahiro Kodama
    Tomohide Tatsumi
    Tomomi Yamada
    Tetsuo Takehara
    Journal of Gastroenterology, 2021, 56 : 67 - 77
  • [47] TREATMENT OUTCOMES OF SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR AMONG NS5A INHIBITOR-EXPERIENCED PATIENTS WITH HEPATITIS C: REAL-WORLD DATA FROM A MULTICENTER ASIAN REGISTRY
    Wong, Yu Jun
    Kumar, Rajneesh
    Kumar, Rahul
    Tan, Jessica
    Liu, Chenhua
    Hui, Vicki Wing Ki
    Tan, Seok Siam
    Kao, Jia-Horng
    Wong, Lai Hung
    Thurairajah, Prem Harichander
    HEPATOLOGY, 2022, 76 : S348 - S349
  • [48] Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
    Johnson, Steven W.
    Ammirati, Shelby R.
    Hartis, Charles E.
    Weber, Stephen F.
    Morgan, Michael R.
    Darnell, Timothy A.
    Silwal, Adwait
    Schmidlin, Holly N.
    Priest, David H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 778 - 781
  • [49] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
    Tahata, Yuki
    Hikita, Hayato
    Mochida, Satoshi
    Kawada, Norifumi
    Enomoto, Nobuyuki
    Ido, Akio
    Yoshiji, Hitoshi
    Miki, Daiki
    Hiasa, Yoichi
    Takikawa, Yasuhiro
    Sakamori, Ryotaro
    Kurosaki, Masayuki
    Yatsuhashi, Hiroshi
    Tateishi, Ryosuke
    Ueno, Yoshiyuki
    Itoh, Yoshito
    Yamashita, Taro
    Kanto, Tatsuya
    Suda, Goki
    Nakamoto, Yasunari
    Kato, Naoya
    Asahina, Yasuhiro
    Matsuura, Kentaro
    Terai, Shuji
    Nakao, Kazuhiko
    Shimizu, Masahito
    Takami, Taro
    Akuta, Norio
    Yamada, Ryoko
    Kodama, Takahiro
    Tatsumi, Tomohide
    Yamada, Tomomi
    Takehara, Tetsuo
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (01) : 67 - 77
  • [50] SOFOSBUVIR/VELPATASVIR EFFECTIVENESS IN TREATING CHRONIC HEPATITIS C GENOTYPE 3: A REAL-WORLD STUDY IN XINJIANG, CHINA
    Sun, Wei
    Aliturson, Maimaiti
    HEPATOLOGY, 2024, 80 : S365 - S365
12345